Iovance Biotherapeutics background photo
Iovance Biotherapeutics profile photo

Iovance Biotherapeutics Careers, Benefits, Review

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack can...

Website Globe icon www.iovance.com

Photo of the Rise UserPhoto of the Rise UserPhoto of the Rise UserPhoto of the Rise UserPhoto of the Rise User
25 fans
Iovance Biotherapeutics Glassdoor Company Review
3.1 Glassdoor star iconGlassdoor star iconGlassdoor star icon Glassdoor star icon Glassdoor star icon
Iovance Biotherapeutics DE&I Review
3.6 Glassdoor star iconGlassdoor star iconGlassdoor star icon Glassdoor star icon Glassdoor star icon
CEO of Iovance Biotherapeutics
Iovance Biotherapeutics CEO photo
Fred Vogt
Approve of CEO